Nurse-initiated steroids improve pediatric asthma care

Nurse-Initiated steroids improve pediatric asthma care
Nurse initiation of oral corticosteroids before physician assessment of pediatric patients with asthma improves quality and efficiency of care provided in the pediatric emergency department, according to a study published online March 19 in Pediatrics.

(HealthDay) -- Nurse initiation of oral corticosteroids before physician assessment of pediatric patients with asthma improves quality and efficiency of care provided in the pediatric emergency department, according to a study published online March 19 in Pediatrics.

Roger Zemek, M.D., from the University of Ottawa in Canada, and colleagues evaluated nurse initiation of treatment with in children with Pediatric Respiratory Assessment Measure score ≥4. One-to-one periods (physician-initiated and nurse-initiated) were analyzed. In both phases, triage nurses initiated bronchodilator therapy before physician assessment, per Pediatric Respiratory Assessment Measure score. The researchers reviewed charts of 644 consecutive children (aged 2 to 17 years) for outcomes, including admission rate; time to clinical improvement, steroid receipt, mild status, and discharge; and rate of return emergency department visit and subsequent admission.

The researchers found that children treated in the nurse-initiated phase improved significantly earlier compared with those treated in the physician-initiated phase (median difference, 24 minutes). Admission was significantly less likely if children received steroids at triage (odds ratio, 0.56). Significant efficiency gains were made in time to steroid receipt (median difference, 44 minutes), time to mild status (51 minutes), and time to discharge (44 minutes). No differences were observed in return visit rate or subsequent admission.

"Triage nurse initiation of oral corticosteroid before physician assessment was associated with reduced times to clinical improvement and discharge, and reduced admission rates in children presenting with moderate to severe acute exacerbations," the authors write.

One author disclosed financial ties to the pharmaceutical industry.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Steroids to treat asthma: How safe are they?

Feb 24, 2011

Children experiencing an asthma attack who are treated with a short burst of oral steroids may have a transient depression of immune response according to a new study led by Université de Montréal. These findings, ...

Recommended for you

Brain neuroinflammation seen in chronic fatigue syndrome

Apr 11, 2014

(HealthDay)—Neuroinflammation markers are elevated in the brains of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) patients compared to healthy controls, according to a study published online ...

Which asthma drugs, dosages work best for African Americans?

Feb 19, 2014

The University of Illinois at Chicago has received funding from the National Institutes of Health to determine what combination and dosages of asthma medications works best to manage asthma in African Americans, who suffer ...

User comments